Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
Lonza to acquire Synaffix B.V., an innovative biotech company focused on antibody-drug conjugates (ADCs) Acquisition w…
Lonza to acquire Synaffix B.V., an innovative biotech company focused on antibody-drug conjugates (ADCs) Acquisition w…
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launc…
SCIEX, a global leader in life science analytical technologies, featured the X500B Quadrupole Time-of-Flight (QTOF) Syst…
SCIEX, a global leader in life science analytical technologies, today announced the latest additions to its growing line…
. GlymaxX® GlymaxX® is a technology to permanently modify animal cells to produce afucosylated antibodies/proteins (ha…
Icon Genetics GmbH, Munich, Germany (ICON) and Bayer CropScience have successfully created a novel plant host system for…
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its new alpha-2,6-Sialyltransferase for in vitro sialyl…
Vom 20. bis 22. März 2013 findet das siebte Glycan Forum Berlin statt. Die Konferenz führt internationale Spitzenforsche…